Tumour-associated macrophages as treatment targets in oncology

Alberto Mantovani; Federica Marchesi; Alberto Malesci; Luigi Laghi; Paola Allavena

doi:10.1038/nrclinonc.2016.217

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2006

Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy

Antonio Sica, Tiziana Schioppa, Alberto Mantovani, Paola Allavena

Article2017

Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models

Cristina Belgiovine, Ezia Bello, Manuela Liguori, Ilaria Craparotta, Laura Mannarino, Lara Paracchini, Luca Beltrame, Sergio Marchini, Carlos M. Galmarini, Alberto Mantovani, Roberta Frapolli, Paola Allavena, Maurizio D’Incalci

Article2022

Macrophages as tools and targets in cancer therapy

Alberto Mantovani, Paola Allavena, Federica Marchesi, Cecília Garlanda

Article2004

Infiltration of Tumours by Macrophages and Dendritic Cells: Tumour‐Associated Macrophages as a Paradigm for Polarized M2 Mononuclear Phagocytes

Alberto Mantovani, Silvano Sozzani, Massimo Locati, Tiziana Schioppa, Alessandra Saccani, Paola Allavena, Antonio Sica

Dataset

Faculty Opinions recommendation of Functional polarization of tumour-associated macrophages by tumour-derived lactic acid.

Alberto Mantovani